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Abstract
Agomelatine, a novel antidepressant with established clinical eﬃcacy, acts as a melatonin receptor agonist
and 5-HT2C receptor antagonist. As stress is a signiﬁcant risk factor in the development of depression, we
sought to determine if chronic agomelatine treatment would block the stress-induced impairment of
memory in rats trained in the radial-arm water maze (RAWM), a hippocampus-dependent spatial mem-
ory task. Moreover, since neural cell adhesion molecule (NCAM) is known to be critically involved in
memory consolidation and synaptic plasticity, we evaluated the eﬀects of agomelatine on NCAM, and
polysialylated NCAM (PSA-NCAM) expression in rats given spatial memory training with or without
predator stress. Adult male rats were pre-treated with agomelatine (10 mg/kg i.p., daily for 22 d),
followed by a single day of RAWM training and memory testing. Rats were given 12 training trials and
then they were placed either in their home cages (no stress) or near a cat (predator stress). Thirty minutes
later the rats were given a memory test trial followed immediately by brain extraction. We found that :
(1) agomelatine blocked the predator stress-induced impairment of spatial memory ; (2) agomelatine-
treated stressed, as well as non-stressed, rats exhibited a rapid training-induced increase in the expression
of synaptic NCAM in the ventral hippocampus ; and (3) agomelatine treatment blocked the water-maze
training-induced decrease in PSA-NCAM levels in both stressed and non-stressed animals. This work
provides novel observations which indicate that agomelatine blocks the adverse eﬀects of stress on
hippocampus-dependent memory and activates molecular mechanisms of memory storage in response to
a learning experience.
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Introduction
Agomelatine is a novel antidepressant which acts as
an agonist of melatonergic MT1 and MT2 receptors
(Ying et al., 1996 ; Yous et al., 1992) and as an antagonist
of 5-HT2C receptors (Chagraoui et al., 2003 ; Millan
et al., 2003). Clinical trials have shown that ago-
melatine has a powerful antidepressant eﬃcacy
(Kennedy and Emsley, 2006 ; Loo et al., 2002 ; Olie and
Kasper, 2007) with fewer side-eﬀects than are found
with other commonly prescribed antidepressants
(Kennedy and Emsley, 2006 ; Montgomery, 2006) Ago-
melatine is an eﬀective treatment for depression be-
cause it resynchronizes disrupted circadian rhythms
(Armstrong et al., 1993 ; Martinet et al., 1996 ; Quera
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Salva et al., 2007 ; Redman et al., 1995 ; Van Reeth et al.,
1997) which are disturbed in depression. Indeed, re-
searchers have long speculated that the disorganiz-
ation of internal circadian rhythms plays a critical role
in the development of major depression (Armitage,
2007 ; Goodwin et al., 1982 ; Hallonquist et al., 1986;
Healy and Waterhouse, 1995 ; McClung, 2007).
In preclinical studies on rodents, agomelatine has
been shown to have both antidepressant (Barden et al.,
2005 ; Bourin et al., 2004) and anxiolytic (Millan et al.,
2005 ; Papp et al., 2006) properties. Chronic adminis-
tration of agomelatine improves avoidance learning
deﬁcits induced in the learned helplessness model
of depression (Bertaina-Anglade et al., 2006) and pro-
duces antidepressant-like eﬀects in the chronic mild
stress model of depression (Papp et al., 2003). Stress
is a known risk factor in the development of many
neuropsychiatric disorders, including depression
(Bremner and Vermetten, 2001 ; Heim and Nemeroﬀ,
1999 ;Mazure, 1995 ; Tsuang, 2000).Moreover, as stress-
inducedmemory impairments are commonly reported
in stress-related psychopathologies (de Quervain
et al., 2000 ; Kirschbaum et al., 1996), there is thera-
peutic relevance to the use of antidepressant treat-
ments to prevent stress-induced cognitive deﬁcits.
For example, there is considerable work showing
that the adverse eﬀects of acute and chronic stress
on diverse hippocampal functions can be blocked
by treatment of rats with antidepressants that have
serotonergic (Hitoshi et al., 2007), as well as non-
serotonergic (Campbell et al., 2008 ; Diamond et al.,
2004 ; McEwen and Olie, 2005 ; Vouimba et al., 2006),
modes of action.
At a more reductionistic level of analysis, extensive
research has revealed evidence of structural changes
in the brain and impairments of neuroplasticity in
response to stress and depression. Clinical studies
have described decreases in hippocampal volume
in patients with stress-related major depression
(Bremner et al., 2000; MacQueen et al., 2003 ; Sheline
et al., 2003; Stockmeier et al., 2004), and chronic
stress in rats alters synaptic morphology in the CA1
(Donohue et al., 2006) and CA3 (Stewart et al., 2005)
regions of the hippocampus. Changes in molecular
forms of plasticity in stress and depression have been
described, as well. For example, the three main iso-
forms of the neural cell adhesion molecule (NCAM),
consisting of NCAM-180, -140 and -120, abundantly
expressed proteins which are critically involved in
memory consolidation (Foley et al., 2000 ; Venero et al.,
2006), and whose expression is markedly reduced in
the hippocampus following chronic stress exposure
(Sandi et al., 2001). In related work, we reported that
NCAM is a central regulator of the pro-plasticity ef-
fects of learning and the anti-cognitive eﬀects of stress.
Correspondingly, hippocampal NCAM expression is
decreased in response to stress (Touyarot and Sandi,
2002) and is up-regulated in response to learning
(Venero et al., 2006). We have also shown that a re-
duction in hippocampal and prefrontal cortex NCAM
expression correlates with predator stress-induced
memory impairments in rats (Sandi et al., 2005). As
prior work has demonstrated that chronic stress can
reduce NCAM mRNA levels and that this eﬀect can
be reversed with antidepressant treatment (Alfonso
et al., 2006), we evaluated here, whether NCAM ex-
pression would be a molecular correlate associated
with agomelatine-induced changes in stress-memory
interactions. Importantly, previous studies would sup-
port the role of NCAM as a downstream target of
agomelatine treatment. For example, 7 d treatment
with melatonin has been shown to enhance hippo-
campal NCAM-180 (Baydas et al., 2002) and learning
and memory (Baydas et al., 2005).
The polysialylated form of NCAM (PSA-NCAM)
is also a powerful mediator of synaptic plasticity.
Learning in a number of hippocampal-dependent
memory tasks increases the expression of PSA-NCAM
(Lopez-Fernandez et al., 2007 ; Murphy et al., 1996;
Venero et al., 2006). Moreover, chronic treatment of
rats with the antidepressant imipramine increases
hippocampal PSA-NCAM expression (Sairanen et al.,
2007). Similarly, chronic treatment with ﬂuoxetine in-
creases PSA-NCAM levels in CA3 stratum lucidum of
the hippocampus (Varea et al., 2007b), and also PSA-
NCAM expression in the prefrontal cortex (Varea
et al., 2007a). Cognition-enhancing therapies also
increase hippocampal expression of PSA-NCAM
(Murphy et al., 2006). Therefore, we addressed here
the eﬀects of agomelatine in the modulation of this
plasticity marker in the dorsal, as well as the ventral,
hippocampus.
Overall, the goal of the present study was to inves-
tigate whether chronic agomelatine treatment can
protect hippocampus-dependent memory from being
impaired by acute predator stress. Rats were trained in
the radial-arm water maze (RAWM), a hippocampus-
dependent spatial memory task (Campbell et al., 2008 ;
Diamond et al., 2006 ; Park et al., 2006 ; Sandi et al.,
2005 ; Woodson et al., 2003; Zoladz et al., 2006), to
learn the location of a hidden escape platform
in a water maze. Once the rats learned the platform’s
location they were exposed to a cat, a powerful fear-
provoking stressor that impairs hippocampus-
dependent spatial memory (Alfonso et al., 2006;
Campbell et al., 2008; Diamond et al., 1999, 2004, 2006;
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Park et al., 2006 ; Woodson et al., 2003) and blocks
hippocampal synaptic plasticity (long-term poten-
tiation ; LTP) (Mesches et al., 1999 ; Vouimba et al.,
2006). Studies have shown that stress-induced impair-
ments of memory and LTP can be reversed by anti-
depressants, including ﬂuoxetine and tianeptine
(Rocher et al., 2004 ; Shakesby et al., 2002 ; Vouimba
et al., 2006). Therefore, in the present study we have
combined the study of antidepressant treatment with
an examination of the molecular mechanisms of stress-
memory interactions in rats. Speciﬁcally, we have
tested the hypothesis that agomelatine will improve
memory performance under stress conditions via a
mechanism that involves training-induced alterations
in hippocampal NCAM and PSA-NCAM expression.
Our work focused on analysis of the dorsal and
ventral divisions of the hippocampus, based on their
diﬀerential involvement in emotional and cognitive
components of memory processing (Bannerman et al.,
2004).
Material and Methods
Animals
Sprague–Dawley rats (Harlan, Indianapolis, IN, USA),
weighing y300 g at the time of testing, were housed
on a 12-h light–dark schedule (lights on 07:00 hours) in
Plexiglas cages (two per cage) with food and water
provided ad libitum. Colony room temperature and
humidity were maintained, respectively, at 20¡1 xC.
All rats were given 1 wk to acclimate to the housing
room environment before any experimental manipu-
lations took place. The Institutional Animal Care and
Use Committee at the University of South Florida ap-
proved all procedures.
Pharmacological agents and treatment regimen
Rats were treated daily with intraperitoneal (i.p.) in-
jections of agomelatine (Servier Pharmaceuticals,
Orleans, France), at a dose of 10 mg/kg, or vehicle
(1 ml/kg; a 1% solution of hydroxyethylcellulose). All
injections occurred at 17:00 hours (2 h before lights oﬀ)
and continued daily for 22 d.
On the ﬁnal day of injections (day 22), a sub-
group of vehicle-treated (baseline vehicle, n=5) and
agomelatine-treated (baseline agomelatine, n=5) ani-
mals were sacriﬁced without behavioural testing to
examine the eﬀects of agomelatine on basal NCAM
and corticosterone levels. The remaining rats under-
went training in the RAWM. All behavioural testing,
tissue harvesting and blood sampling took place 2–5 h
following the ﬁnal injection, between 19:00 and 22:00
hours.
RAWM
The RAWM task has been described previously
(Campbell et al., 2008 ; Diamond et al., 2006; Park et al.,
2006 ; Sandi et al., 2005 ; Woodson et al., 2003 ; Zoladz
et al., 2006). Brieﬂy, the RAWM consists of a black,
galvanized round tank (168 cm diameter, 56 cm
height, 43 cm depth) ﬁlled with clear water (22 xC). Six
V-shaped stainless steel inserts (54 cm height, 56 cm
length) were positioned in the tank to produce six
swim arms radiating from an open central area.
A black, plastic platform (12 cm diameter) was located
1 cm below the surface of the water at the end of one
arm (referred to as the ‘goal arm’). At the start of each
trial, rats were released in one arm (referred to as the
‘start arm’) facing the centre of the maze. If a rat did
not locate the hidden platform within 60 s, it was
guided to the platform by the experimenter. Once a rat
found or was guided to the platform, it was left there
undisturbed for 15 s. An arm entry was operationally
deﬁned as the rat passing at least halfway down the
arm. For each trial, the experimenter recorded the
number of arm entry errors and latency for the rat to
ﬁnd the platform. An arm entry error consisted of the
rat entering an arm that did not contain the hidden
platform or, in rare circumstances, entering the goal
arm and not climbing on the platform. The goal arm
was diﬀerent across rats within a day to eliminate a
scent build-up in the vicinity of the hidden platform.
The start arms varied pseudo-randomly across trials
so that a diﬀerent start arm was used on sequential
trials.
Rats were given 12 acquisition trials (T1–T12) to
locate the hidden platform. Immediately after trial 12
they were either exposed to a cat (see ‘Predator stress’
below) or placed in their home cages for 30 min.
Following this 30-min period, all rats were given a
single memory test trial to assess their memory for
the platform location. This resulted in four RAWM-
trained groups: vehicle-no stress, vehicle-stress, ago-
melatine-no stress and agomelatine-stress.
Predator stress
Rats in the stress groups were placed in a small clear
Plexiglas box (25r10r15 cm) with numerous small
(1 cm diameter) holes. Then the rats were transported,
in the box, to the cat housing room, where they were
placed in a large cage (61r53r51 cm) with an adult
gonadally intact female cat for 30 min. The Plexiglas
box prevented any physical contact between the rats
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and cat, but enabled the rats to be exposed to all non-
tactile sensory stimuli generated by the cat. Canned
cat food was smeared on the top of the Plexiglas box to
direct cat activity toward the rats.
Tissue preparation
Immediately following the 30-min memory test, rats
were rapidly decapitated, their brains were removed
and a sample of trunk blood was collected. The brains
were kept on a cold plate and each hippocampus
was dissected out and divided into dorsal and ventral
sections. The tissue was stored at x80 xC until ana-
lysed.
Crude synaptosomal pellets were obtained accord-
ing to a modiﬁed protocol from Lynch and Voss
(1991). In brief, tissue was homogenized in 10 vol ice-
cold sucrose (0.32 M) and Hepes (4 mM) containing
a cocktail of protease inhibitors (Complete TM,
Boehringer Mannheim, Lewes, UK) with 16 strokes
and centrifuged at 1000 g for 5 min. The supernatant
was centrifuged at 15 000 g for 15 min, and the pellet
re-suspended in PBS, containing protease inhibitors.
Protein concentration were estimated by the method
of Lowry et al. (1951).
Quantitative immunoblotting of NCAM
Two major NCAM isoforms, NCAM-140 and NCAM-
180, were measured in crude synaptosomal prepa-
rations by Western blotting. Synaptosomal samples
from each rat were incubated overnight at room tem-
perature with EndoN (AbCys, Paris, France ; ﬁnal di-
lution 1:120) to selectively cleave the PSA moiety of
NCAM. The reaction was stopped by boiling samples
at 100 xC for 5 min in 70 mM Tris–HCl (pH 6.8), 33 mM
NaCl, 1 mMEDTA, 2% (w/v) sodiumdodecyl sulphate,
0.01% (w/v) Bromophenol Blue, 10% glycerol and 3%
(v/v) dithiothreitol. Then 15 mg of each sample was
separated on 7.5% (w/v) SDS–PAGE and transferred
to nitrocellulose membrane (Biotran BA85, Schleicher
& Schuell). After saturation of non-speciﬁc sites with
5% (w/v) skimmed milk in 10 mM Tris–HCl (pH 7.4),
containing 150 mM NaCl, 0.05% (v/v) Tween-20
(TBST), blots were incubated for 2 h at room tem-
perature with polyclonal rabbit anti-NCAM (1:5000)
(Millipore, Zug, Switzerland), then washed with
TBST, incubated for 1 h with secondary antibody
(Molecular Probes, Basel, Switzerland), and ﬁnally de-
veloped using the SuperSignal West Dura Substrate
(Pierce, Rockford, IL, USA). Bands were detected
using the ChemiDoc XRS system (Bio-Rad, Hercules,
CA, USA) and quantiﬁed using Quantity One1 soft-
ware (Bio-Rad). The sum of the intensities of the pixels
within a volume boundary multiplied by pixel area
was determined for each band. Expression of NCAM
in each group was expressed as a percent change
from basal level (combination of basal vehicle and
agomelatine-treated samples).
PSA-NCAM ELISA
PSA-NCAM was quantiﬁed by ELISA, according to a
previously described protocol (Merino et al., 2000). In
brief, a ﬂat-bottomed 96-well microplate was allowed
to absorb a coating solution [0.1 M Na2CO3/0.1 M
NaHCO3 (pH 9.4)] for 2 h at room temperature. The
solution was removed, and 50 ml of pellet samples
was added at a concentration of 10 mg/ml to each well.
The plates were incubated overnight at 4 xC and then
washed three times with 1 M PBS containing 0.05%
Tween-20 (pH 7.4). Additional binding sites were
blocked with BSA (3%) for 2 h at room temperature.
The wells were rinsed three times and incubated
with 50 ml aliquots of a monoclonal antibody against
PSA-NCAM (AbCys) overnight at 4 xC. Then, the
wells were washed, and 50 ml aliquots of peroxidase-
conjugated second antibody, an IgM anti-mouse
peroxidase conjugate (Sigma-Aldrich, Buchs, Switzer-
land) at a 1:1000 dilution, was added for a 2-h incu-
bation period. Afterwards, 50 ml of citrate buﬀer
[50 mM Na2HPO4, 25 mM citric acid (pH 4.5)] contain-
ing 1 mg/ml o-phenylene diamine and 0.06% H2O2,
added just before use, was placed in each well, and
allowed to react for 10 min at room temperature. The
reaction was terminated by the addition of 50 ml
of 10 M H2SO4 to each well. The optical density
was determined by measuring absorbency at 492 nm
with a Microplate Reader (GE-Bioscience, Otelﬁngen,
Switzerland).
Corticosterone assay
The blood collected at time of sacriﬁce was centrifuged
(3000 rpm for 5 min at 4 xC), and the serum was ex-
tracted and stored at x80 xC until it was assayed for
corticosterone by an ELISA immunoassay kit (Assay
Design, Ann Arbor, MI, USA).
Statistics
Arm entry errors made in the RAWM during the ac-
quisition phase (T1–T12) and on the 30-min memory
test (T13) were analysed separately using SPSS soft-
ware (SPSS Inc., Chicago, IL, USA). The acquisition
phase was analysed with a mixed-model ANOVA,
with group serving as the between-subjects factor and
trial serving as the within-subjects factor. Performance
on the 30-min memory test trial was analysed with a
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one-way ANOVA, with group serving as the between-
subjects factor.
The levels of NCAM and PSA-NCAM in all water
maze-trained groups were expressed as a percent of
baseline. NCAM data were analysed with one-way
ANOVAs on NCAM-180 and NCAM-140 expression,
with group serving as the between-subjects factor in
each analysis. PSA-NCAM and serum corticosterone
data were analysed with one-way ANOVAs, with
group serving as the between-subjects factor. Alpha
was set at 0.05 for all analyses, and Bonferroni-
corrected post-hoc tests were used when necessary. In
all ﬁgures, the data are presented as means¡S.E.M.
Results
RAWM
Analysis of the acquisition phase revealed a signiﬁ-
cant main eﬀect of trial [F(7, 294)=17.37, p<0.0001],
indicating that the groups made fewer errors, i.e.
learned the location of the hidden platform, as the
trials progressed (Figure 1). There was no signiﬁ-
cant eﬀect of group [F(1, 44)=0.19, p>0.90], and
the trialrgroup interaction was not signiﬁcant
[F(20, 294)=0.79, p>0.1]. Analysis of performance on
the 30-min memory test trial revealed a signiﬁcant
main eﬀect of group [F(3, 44)=13.00, p<0.0001].
Bonferroni post-hoc tests indicated that the vehicle-
treated group exposed to predator stress during
the 30-min delay period made signiﬁcantly more
errors than all other groups (p<0.001). In contrast,
the agomelatine-treated group exposed to predator
stress (0.75¡0.36 errors) was not signiﬁcantly diﬀerent
from the vehicle-treated (0.25¡0.11 errors) and ago-
melatine-treated (0.50¡0.24 errors) no-stress groups,
indicating chronic agomelatine treatment blocked the
amnesic eﬀects of predator stress on hippocampus-
dependent spatial memory (Figure 1).
NCAM-180 and NCAM-140
Chronic treatment with agomelatine in the absence
of water-maze training had no signiﬁcant eﬀect on
ventral hippocampus synaptic NCAM-180 expres-
sion [vehicle : 100.2¡12.92 vs. agomelatine : 99.77¡
8.16 ; t(8)=0.03, p>0.97] and NCAM-140 [vehicle :
110.8¡10.74 vs. agomelatine : 89.16¡5.29 ; t(8)=1.81,
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Figure 1. Chronic agomelatine treatment prevented the predator stress-induced impairment of spatial memory in the radial-arm
water maze. During acquisition, the groups learned the location of the hidden platform at equivalent rates. Predator stress
during the 30-min delay period between learning and retention (indicated by the shaded grey bar) impaired memory retrieval in
the vehicle-treated, but not agomelatine-treated, group. The data are presented as mean number of arm entry errors (¡S.E.M.)
made during acquisition (two-trial blocks) and on the retention trial (RT). The dashed line at 2.5 errors indicates chance level of
performance (Diamond et al., 1999). * p<0.001 compared to all other groups (Bonferroni post-hoc tests).
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p>0.10]. Therefore, to increase the power of the stat-
istical analysis, data from these two groups were
combined into one group, which is referred to as
‘basal level NCAM’. All total NCAM expression in the
four water-maze-trained groups was expressed as a
percent of basal level. A one-way ANOVA for total
NCAM revealed a signiﬁcant main eﬀect of group
[F(4, 38)=6.05, p<0.001]. Bonferroni post-hoc tests
indicated total NCAM expression in the ventral
hippocampus was signiﬁcantly elevated in the ago-
melatine-treated no-stress (127.84¡12.71) and agomel-
atine-treated stress (143.07¡7.44) groups, compared
to the vehicle-treated no-stress (95.94¡4.83%) and
vehicle-treated stress (109.64¡3.62%) groups (p val-
ues<0.05) (Figure 2).
A one-way ANOVA performed on the NCAM-180
data indicated a signiﬁcant main eﬀect of group
[F(4, 38)=4.442, p<0.01]. Bonferroni post-hoc test
demonstrated that NCAM-180 was signiﬁcantly elev-
ated in the agomelatine-treated no-stress group
(127.24¡11.36) compared to the vehicle-treated no
-tress group (92.69¡4.83) (p<0.05). Vehicle-treated
stress NCAM-180 (105.70¡3.63) was not signiﬁcantly
diﬀerent from that of the agomelatine-treated stress
group (120.36¡6.89), again agomelatine tended to
enhance NCAM-180 expression following RAWM
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Figure 2. Neural cell adhesion molecule (NCAM)-180 and NCAM-140 expression in the ventral hippocampus was examined
in vehicle- and agomelatine-treated animals under basal and post-water maze training conditions, with and without predator
stress. (a) Representative immunoblots from ventral hippocampal crude synaptosomal extracts. (b) Agomelatine-treated
animals, independent of stress exposure, had enhanced expression of overall NCAM following water maze training.
(c) NCAM-180 expression was signiﬁcantly increased in the agomelatine-treated no-stress group, relative to the vehicle-treated
no-stress group. (d) NCAM-140 expression was signiﬁcantly increased in the agomelatine-treated stress group, relative to the
vehicle-treated stress group. In all panels, NCAM expression (quantitative densitometric analysis) is displayed as a percent
change from basal expression (i.e. basal vehicle and basal agomelatine combined). Values shown are the mean¡S.E.M. The
sample sizes were : basal vehicle (n=5), basal agomelatine (n=5), no stress-vehicle (n=13), no stress-agomelatine (n=5),
stress-vehicle (n=8) and stress-agomelatine (n=7). * p<0.05 compared to the respective vehicle-treated group (Bonferroni
post-hoc tests).
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training in combination with predator stress. There
was no signiﬁcant diﬀerence in NCAM-180 expression
in vehicle-treated vs. vehicle-treated stress animals, or
in either of these groups compared to basal NCAM
expression.
A one-way ANOVA performed on the NCAM-140
data indicated a signiﬁcant main eﬀect of group
[F(4, 38)=5.38, p<0.01]. Bonferroni post-hoc tests re-
vealed that NCAM-140 expression was signiﬁcantly
elevated in the agomelatine-treated stress group
(165.24¡26.16) compared to the vehicle-treated stress
group (113.59¡6.03) (p<0.05). Vehicle-treated ex-
pression (99.20¡6.48) was not signiﬁcantly diﬀerent
from that of the agomelatine-treated group (128.45¡
9.08). There was no signiﬁcant diﬀerence in NCAM-
140 expression in vehicle-treated vs. vehicle-treated
stress animals, or in either of these groups compared
to basal NCAM expression.
In contrast to the ventral hippocampus, we found
no signiﬁcant change in NCAM expression in the
dorsal hippocampus under any condition (all statisti-
cal comparisons, p>0.1 ; data not shown).
PSA-NCAM
Polysialylation of the NCAM molecule has been
shown to be induced by learning and memory (Lopez-
Fernandez et al., 2007 ; Sandi et al., 2003), as well as by
administration of ﬂuoxetine (Varea et al., 2007a,b).
Therefore, we assessed the eﬀects of agomelatine
treatment and spatial learning and memory on PSA-
NCAM expression in the ventral hippocampus.
Chronic treatment with agomelatine had no eﬀect
on basal expression of PSA-NCAM in the ventral
hippocampus [vehicle : 106.74¡6.54 vs. agomelatine :
93.26¡4.38 ; t(8)=1.71, p=0.12]. Therefore, the vehicle
baseline and agomelatine baseline groups were com-
bined, and PSA-NCAM expression in the remaining
four groups was expressed as a percent of basal level.
A one-way ANOVA on PSA-NCAM expression re-
vealed a main eﬀect of group [F(4, 37)=3.95, p<0.01].
Bonferroni post-hoc tests indicated that RAWM train-
ing (vehicle-no stress : 85.60¡2.55%) induced a sig-
niﬁcant reduction of PSA-NCAM expression in the
ventral hippocampus, relative to baseline (100.00¡
4.57%) (p<0.05) (see Figure 3). A reduction in PSA-
NCAM expression was also observed following
water-maze training combined with predator stress
(vehicle-stress : 78.69¡7.6%). Chronic agomelatine
treatment ameliorated the training-induced reduction
of PSA-NCAM expression in the no-stress group
(95.16¡4.16%) as well as the stress group (87.75¡
2.11) (p<0.05).
As with NCAM expression, we found no signiﬁcant
changes in any measure of PSA-NCAM levels in
the dorsal hippocampus (all p values >0.1) (data not
shown).
Serum corticosterone levels
We examined the eﬀect of chronic agomelatine treat-
ment on basal and post-training serum corticosterone
levels. Chronic treatment with agomelatine had
no eﬀect on basal corticosterone relative to the ve-
hicle-treated group [197.2¡29.57 ng/ml vs. 183.6¡
13.37 ng/ml; t(12)=0.42, p>0.68]. Therefore, to in-
crease the power of the statistical analysis we com-
bined the data from these two groups to form a single
baseline measure. A one-way ANOVA on serum cor-
ticosterone levels revealed a main eﬀect of group
[F(4, 47)=7.43, p<0.001]. Bonferroni post-hoc tests
indicated that both of the trained stress groups (i.e.
vehicle-stress and agomelatine-stress) had signiﬁ-
cantly greater serum corticosterone levels than base-
line (p<0.05) (see Figure 4).
Discussion
There were three primary ﬁndings in the present
study. First, and most important, chronic agomelatine
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Figure 3. Polysialylated neural cell adhesion molecule
(PSA-NCAM) expression in the ventral hippocampus was
examined in vehicle- and agomelatine-treated animals under
basal and post-radial-arm water maze (RAWM) (¡stress)
conditions. The vehicle-treated groups trained in the water
maze, exhibited a signiﬁcant reduction of PSA-NCAM
expression, independent of stress exposure compared to
basal conditions. Chronic agomelatine treatment blocked this
training-induced reduction of PSA-NCAM expression in
non-stressed and stressed conditions. The sample sizes were :
basal (n=10), no stress-vehicle (n=10), no stress-agomelatine
(n=5), stress-vehicle (n=8) and stress-agomelatine (n=7).
* p<0.05 compared to the basal group (Bonferroni post-hoc
tests).
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treatment prevented the predator stress-induced im-
pairment of spatial memory. This memory-protective
eﬀect of agomelatine was accomplished indepen-
dently of any general eﬀects of the treatment on
hypothalamus–pituitary–adrenal axis, as we did not
observe an eﬀect of agomelatine on the stress-induced
increase in serum corticosterone levels. This result is
in agreement with previous data where no eﬀect
of agomelatine was observed on corticosterone after
immobilization stress in transgenic mice with low
glucocorticoid receptor function (Barden et al., 2005).
Second, rats treated with agomelatine exhibited a
rapid (within 30 min) learning-induced increase in
total NCAM in the ventral hippocampus, as analysed
in the synaptosomal fraction. Indeed, rats trained in
the RAWM exhibited a signiﬁcant increase in NCAM
only if they had been chronically treated with agomel-
atine. This increase in NCAM expression occurred in
stressed as well as non-stressed rats, indicating that it
was speciﬁcally induced by agomelatine interacting
with learning and memory consolidation processes.
Previous studies focusing only on the 24-h post-water-
maze training time-point showed that synaptically
localized NCAM levels are elevated in the hippocam-
pus (Venero et al., 2006). Here, we show that chronic
agomelatine treatment primed the hippocampus of
rats in such a way that training animals in the water
maze led to what appears to be an ‘accelerated’ ex-
pression of NCAM levels in the rat hippocampus
within 30 min for both the stress and no-stress groups.
It should be noted that melatonin, which also has anti-
depressive properties, has also previously been shown
to enhance NCAM-180 and NCAM-140 expression
(Baydas et al., 2002, 2005).
Third, agomelatine prevented the reduction in PSA-
NCAM expression occurring in the synaptosomal
fraction of the ventral hippocampus 30 min after
water-maze training, an eﬀect which was found in
both stressed and non-stressed vehicle-treated trained
animals (i.e. the eﬀect occurred independently of the
predator stress manipulation and was found only in
trained rats). A rapid reduction in PSA-NCAM was
previously shown within 15 min of NMDA receptor-
dependent stimulation of synapses in the adult dorsal
vagal complex (Bouzioukh et al., 2001). PSA-NCAM
can inhibit glutamate-induced activation of the NR2B
receptors (Hammond et al., 2006), while activation
of NMDA receptors increases NCAM-180 in hippo-
campal slices (Hoﬀman et al., 2001). NMDA receptor
activation is critically involved in the early phase
of spatial learning (Bannerman et al., 1995 ; Morris
et al., 1986 ; Morris, 1989) thus indicating an NMDA-
dependent reduction in PSA-NCAM that may pre-
empt a later modulation in the NCAM expression and
function during memory consolidation.
Although PSA-NCAM in the dentate gyrus has
been linked to neurogenesis (Bonfanti, 2006), there are
many examples in which regulation of hippocampal
PSA-NCAM expression has been dissociated from
neurogenesis (Foley et al., 2008 ; Lopez-Fernandez
et al., 2007 ; Pham et al., 2003). The fact that in our
study the reduction in PSA-NCAM occurred rapidly,
after a single training session, supports the view that
neurogenesis is not implicated in the eﬀect, since
our experimental protocol lasted for <1 h and PSA-
NCAM typically starts in newly generated cells a few
days after proliferation takes place.
One diﬀerence between the present and previous
ﬁndings from our group is that we previously re-
ported that predator exposure produced a rapid
(30 min) reduction in NCAM levels in the dorsal hip-
pocampus of water-maze-trained rats (Sandi et al.,
2005), which was not found in the present study. There
are two primary methodological diﬀerences between
the studies which may provide insight into how
NCAM levels change in the dorsal vs. ventral hippo-
campus under diﬀerent learning and stress conditions.
In our previous work, rats were given two training
sessions which were separated by 1 wk. In that work,
the ﬁrst session gave the rats the opportunity to learn
the task and to acclimate to the water-maze-training
conditions. It was only after the rats were given the
second session, 1 wk later, that they were exposed to
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Figure 4. The vehicle- and agomelatine-treated groups
exposed to a cat for 30 min displayed signiﬁcant elevations
in serum corticosterone levels, relative to baseline. The
sample sizes were : basal (n=10), no stress-vehicle (n=15),
no stress-agomelatine (n=7), stress-vehicle (n=8) and
stress-agomelatine (n=8). * p<0.05 compared to the basal
group (Bonferroni post-hoc tests).
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the cat, which then led to their memory impairment
for that day’s platform location, as well as the rapid
reduction of NCAM levels in the dorsal hippocampus.
In the present study, maze-naive rats were given only
a single water-maze training session, followed either
by control (home cage) or predator stress conditions,
which was terminated by the 30-min memory test.
Therefore, one important diﬀerence between the two
studies was that the rapid NCAM reduction found in
our ﬁrst study was in rats that had already had ex-
perience with spatial learning in the water maze, and
in the present study the rats were naive, and were
therefore presumably more stressed by the training
procedures.
It is also important to note that in our previous
study the rats did not receive any pre-training injec-
tions (Sandi et al., 2005), but in the present study all
animals had been given daily injections of either
vehicle or agomelatine for three consecutive weeks, a
procedure that can be considered a mild chronic stress
protocol. Based on work demonstrating that chronic
stress procedures can result in marked reductions in
NCAM expression (Sandi, 2004), it is possible that the
repeated exposure to daily injections might have
caused, by itself, alterations in NCAM regulation
that might underlie the lack of changes in NCAM
expression in the dorsal hippocampus following
predator stress found in the present study.
One ﬁnal perspective on the ﬁndings of our two
NCAM/predator stress studies is that they may reveal
diﬀerences in functional characteristics between the
dorsal and ventral hippocampus. Studies have shown
that spatial learning can diﬀerentially depend on
the dorsal, but not ventral, hippocampus (Moser et al.,
1993), however, other evidence indicates that the
ventral hippocampus also contributes to spatial
learning. Ferbinteanu et al. (2003) found that lesions of
either the ventral or dorsal hippocampus disrupted
one-trial matching-to-position water-maze learning.
Interestingly, Ferbinteanu et al. reported this ventral
hippocampus role in spatial memory when rats were
trained in relatively cold water (21 xC), while Moser
and colleagues (Moser et al., 1993, 1995) found little
contribution of the ventral hippocampus to spatial
learning when animals were trained with warmer
water (25 xC). Similarly, we previously reported that
altering the water temperature in the water maze ef-
fects the production of corticosterone and the rate of
learning (Akirav et al., 2004 ; Sandi et al., 1997).
Speciﬁcally, rats trained in cold water (19 xC) learned
more rapidly and displayed a greater corticosterone
response than rats trained in warm water (25 xC). The
ventral hippocampus is believed to play a preferential
role in brain processes associated with anxiety-related
behaviours (Bannerman et al., 2004). In situations of
heightened anxiety or stress, such as those associated
with a rat’s ﬁrst exposure to the water maze, the rela-
tive contributions of the ventral and dorsal hippo-
campus to spatial memory processing appear to be
equally distributed. In contrast, when the animals
have had prior experience with water-maze training,
as occurred in our ﬁrst NCAM/water-maze study,
dorsal hippocampus functioning may predominate
because of a reduced anxiety component to water-
maze testing. Although speculative, the ﬁndings of
our two NCAM/water-maze studies suggest that
conditions of heightened anxiety, produced by daily
injections and the rats’ ﬁrst exposure to the water
maze, generated a greater involvement of the ventral
hippocampus in spatial learning and memory pro-
cessing than when the rats were trained under lower
anxiety conditions.
In this study, no diﬀerence in PSA-NCAM ex-
pression in basal conditions was observed after
chronic agomelatine treatment. This result is in
contrast to previously reported ﬁndings where PSA-
NCAM expression decreased after chronic agomel-
atine treatment (Banasr et al., 2006). Factors such as
genetic background (Wistar vs. Sprague–Dawley rats)
and/or diﬀerences in experimental conditions (time of
sampling after drug treatment : 16 h after last drug
treatment in Basnar et al. vs. 30 min in present study)
could explain the diﬀerences in ﬁndings across
studies. Moreover, the study by Banasr et al. examined
PSA-NCAM expression by immunohistochemistry in
an area restricted to the granule cell layer of the ven-
tral part of the dentate gyrus, whereas we examined
overexpression of PSA-NCAM in the synaptosomal
fraction of the ventral hippocampus. In contrast, our
results are in agreement with those obtained by
Morley-Fletcher et al. (unpublished observations) who
have demonstrated that chronic agomelatine does not
aﬀect PSA-NCAM expression in the hippocampus in
control Sprague–Dawley rats, the same as used in the
present study.
Modulations of NCAM and PSA-NCAM are rou-
tinely observed as a result of the induction of synaptic
plasticity, but under normal circumstances, these
molecular changes require 24 h to develop (Venero
et al., 2006). In the present work we found that fol-
lowing chronic agomelatine treatment, learning-
induced changes in NCAM occurred rapidly, detect-
able 30 min after training. Taken together, these results
suggest that agomelatine may have beneﬁcial eﬀects
on cognition in people with depression. Moreover, at a
mechanistic level, the learning-induced enhancement
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of NCAM expression observed in agomelatine-
injected rats might be interpreted as a potential com-
pensatory mechanism to overcome the deleterious
eﬀects induced by other (as yet unknown) mechan-
isms mediating the stress-induced impaired retrieval.
Subsequent work will therefore address the possibility
that chronic treatment with agomelatine may block
the impairing eﬀects of predator stress on long-term
(24 h) spatial memory (Diamond et al., 2006 ; Park
et al., 2008), as well as memory-related changes in
hippocampal dendritic spine density (Diamond et al.,
2006).
Overall, these ﬁndings suggest that agomelatine
potentiates learning-associated synaptic plasticity
by facilitating a rapid training-induced induction
of NCAM in the ventral hippocampus. The precise
cellular/subregional location of the learning and
stress-related changes described in our study can
not be determined from this work. Previous work
with other antidepressants identiﬁed neuropil in the
CA3 stratum lucidum (Varea et al., 2007b) and
the subgranular zone of the dentate gyrus (Sairanen
et al., 2007) as particularly responsive to chronic
ﬂuoxetine and imipramine treatments, respectively,
in terms of changes in PSA-NCAM immunostain-
ing.
In summary, this work provides novel observations
which indicate that agomelatine blocks the adverse
eﬀects of acute stress on relatively short-term (30 min)
hippocampus-dependent memory and rapidly acti-
vates molecular mechanisms of memory storage in
response to a learning experience. Collectively, these
ﬁndings show striking correlations between the
memory-protective eﬀects of agomelatine and the ex-
pression levels of NCAM and its post-translational
modiﬁcation, PSA-NCAM. They suggest that agomel-
atine enables learning to rapidly induce forms of
molecular plasticity which are necessary components
of memory formation.
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